PubMed · 2268358
Superactive insulins.
Abstract
The substitution of aspartic acid for the naturally-occurring histidine residue in position B10 in human insulin results in an insulin analogue which displays an in vitro potency 4- to 5-fold greater than the parent compound. This substitution has been introduced into six insulin analogues which, before modification, display potencies ranging from less than 0.01-fold to 3-fold relative to natural insulin. In each case, the resulting aspartic acid-substituted analogue is substantially more potent than the parent compound. Thus, it is now possible to prepare "tailor-made" insulins with enhanced potency.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
G T Burke, S Q Hu, N Ohta, G P Schwartz, L Zong, P G Katsoyannis. 1990-12-31. Superactive insulins.. https://doi.org/10.1016/s0006-291x(05)80882-4
Cite the original work for its findings. Save a collection to share your selection of sources.